Parenting during the Pandemic: An Interview with Monica Coenraads of the Rett Syndrome Research Trust

/
Parenting during the Pandemic: An Interview with Monica Coenraads of the Rett Syndrome Research Trust

Rett syndrome is a genetic brain disorder caused by mutations in the MECP2 gene. Rett typically affects females and symptoms usually become apparent between six and eighteen months after birth. Symptoms of Rett include the inability to speak, walk, or perform repetitive movements. People with Rett also frequently experience breathing problems, seizures, gastrointestinal and orthopedic issues.

Monica Coenraads is the founder and Executive Director of the Rett Syndrome Research Trust (RSRT). Monica has led RSRT to awarding $66 million in research grants, with the goal of finding a cure for Rett. More importantly, Monica is Chelsea Coenraads’ mom.


Read More

Racial and Ethnic Inequality: A Public Health Perspective

/
Racial and Ethnic Inequality: A Public Health Perspective

If you, or a loved one, are living with a rare disease, you may have gone to doctor after doctor, seeking a diagnosis. You may have spent hours, days, or weeks online, looking for answers or a glimmer of hope. You know the struggle of having a rare disease—lack of research, lack of drugs to treat your condition, and often, many unanswered questions. Now, imagine having a rare disease without access to quality healthcare or high-speed internet to conduct research at home.

Read More

My friend chose an assisted death in Switzerland. Her dying wish was to tell you why

/
My friend chose an assisted death in Switzerland. Her dying wish was to tell you why

By CNN

Shortly after 11 a.m. on December 16, 2019, Cindy Siegel Shepler drew her last breath in a spartan room in Basel, Switzerland.

The 62-year-old American twisted a knob on her IV pole and soon fell asleep for the last time.

I had stayed with her and her husband David in Knoxville, Tennessee, for their last three nights at home before they left for Basel. And I spoke to her for the last time about 12 hours before she died.

Read More

Mike Klein of Genomenon on Rare Revolution Magazine

/
Mike Klein of Genomenon on Rare Revolution Magazine

By Rare Revolution Magaziine

What would you say are some of the biggest motivators for your employees?

We were pretty fired up when Rare Genomics Institute (RGI) shared a case where an undiagnosed patient had their whole exome sequenced and analysed by a leading genetics laboratory. The lab was unable to find evidence on any clinically relevant genetic mutations that could provide a diagnosis. When Dr. Lipika Ray, a computational geneticist at RGI, re-analysed the patient’s DNA using Mastermind, she found a single research report that matched the patient’s DNA data. This finding led to the patient diagnosis and ended their long diagnostic odyssey.

Read More

Cindy Shepler, A Tireless Advocate

/

Rare Genomics Institute had the distinct privilege of working with Cindy Siegel Shepler since 2013, when our organization connected with her in the context of her advocacy for patients with Hailey-Hailey Disease (HHD). We soon discovered that Cindy was an advocate for several other health-focused organizations, and more specifically for individuals who suffered from illnesses. Although Cindy herself suffered from several debilitating illnesses, she worked tirelessly to support others who were in pain. 

In 2013, Cindy approached Rare Genomics with a proposal to test a generically available drug in patients with HHD. Although the project evolved over time, with Cindy's support Rare Genomics eventually published a review article: "Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease?". The mini review summarized the evidence for the effectiveness of LDN for HHD patients, and led to increased awareness in the research and rare disease community. This initiative with Cindy was the inspiration for the creation of the Rare Genomic's Task Force, which aims to provide scientific information and support for patients with rare diseases where an N of 1 matters. 

Cindy was a gifted communicator, tireless advocate, brilliant connector, and an inspiration to our organization. We are grateful for our collaboration with her and join those who knew her in celebrating a life well-lived. 

Rare Genomics Institute Launches the RareWear Program

/

LOS ANGELES, CA; February 25th, 2020 -- Rare Genomics Institute (RG), a non-profit patient advocacy group for rare disease patients, has launched the RareWear program. This philanthropic global program establishes a partnership ecosystem connecting rare disease patients with medical technology companies who can provide these patients with devices to better manage and monitor their conditions. The program will officially start matching patient applications on February 29th, 2020 marking International Rare Disease Day.

Read More

Empowering Rare Disease Patients with Technology: Why the "RareWear" Initiative

/
Empowering Rare Disease Patients with Technology: Why the "RareWear" Initiative

In February of 2020, we at Rare Genomics launched the RareWear Initiative. This program connects rare disease patients with medical device, health monitoring, and wearables companies that contribute technology to empower these patients, their families, and their clinicians. In this blog, we discuss the “Why” behind the RareWear program, and our goals to draw attention and resources to this rare disease patient need.

Read More

Update from Global Genes Summit - A brief chat with Jane Gunther (CureCADASIL Association)

/
Update from Global Genes Summit - A brief chat with Jane Gunther (CureCADASIL Association)

In September, I made my first trip out to the West Coast for my first ever rare disease conference--the Global Genes Patient Advocacy Summit. This conference is the largest gathering of rare disease stakeholders in the world, and it’s an opportunity to meet new people, make connections, and learn from the experts.

Through Jane I learned about a new rare disease, CADASIL, which stands for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. In layman’s terms, CADASIL is a genetically inherited disease where just one defective NOTCH3 gene copy on chromosome 19 (from mom or dad) is enough to cause the small blood vessel walls within the white matter of the brain to thicken, making blood circulation more challenging. Eventually, the poor blood flow can lead to a total blockage that triggers a stroke. This results in brain lesions of dead tissue that are responsible for the subsequent cognitive deficits that ultimately lead to dementia.

Read More

Aware for Rare: Shortage of Genetic Specialists & Dealing with the established standards of Clinical Practice - PART IV

/
Aware for Rare: Shortage of Genetic Specialists & Dealing with the established standards of Clinical Practice - PART IV

Part IV of the series discusses the shortage of genetics specialists, limited medical knowledge, dealing with established standards of clinical practice and the challenge of integrating extensive information.


Read More

Aware for Rare: Exploring Current Challenges in Rare Disease - PART III

/
Aware for Rare: Exploring Current Challenges in Rare Disease - PART III

Part III of the series details some of the other challenges in the rare disease space: continued confusion and not knowing even after diagnosis, scattered rare disease communities, and getting the attention of governments to intervene.


Read More

All of Us Research Program

/
All of Us Research Program

It’s been 16 years since the first human genome was sequenced. That undertaking took almost 15 years, cost billions of dollars, and revolutionized genetic research. Since then, new sequencing technologies have led to lower sequencing costs and quicker turnaround times. Sequencing a genome today takes weeks rather than years and costs thousands, not billions.


Read More

Rare Genomics Institute Uses Genomenon’s Mastermind to Diagnose Patient

/

Rare Genomics Institute says it has successfully diagnosed a previously-undiagnosed patient using Genomenon’s Mastermind Genomic Search Engine. [Genomenon]

Rare Genomics Institute said today it successfully diagnosed a previously undiagnosed patient using Genomenon’s Mastermind Genomic Search Engine.

The announcement, timed to coincide with Rare Disease Day 2019, comes four months after the partners launched a collaboration in which Genomenon agreed to donate licenses allowing clinical scientists working with Rare Genomics Institute to access Mastermind.

Read More

RG Rare Disease Day Acknowledgment: Small steps make a big difference

/
RG Rare Disease Day Acknowledgment: Small steps make a big difference

LOS ANGELES, CA; April 15, 2019 --

Thank you to all our supporters on **Rare Disease Day 2019**, we are so thankful to have a community that is working with us to push science and medicine forward to meet the needs of rare disease patients.

This year we were lucky to have a new community raise awareness with us on Rare Disease Day. We want to thank all Illumina employees who decided to advocate for rare disease patients on this important day. When we say that every bit makes a difference, that is because it makes all the difference, especially for families with significant unmet need.

Read More

Talking to kids about genetic differences- Three great books to share

/
Talking to kids about genetic differences- Three great books to share

It can be difficult to explain complicated genetic topics to children with chromosomal differences, or to discuss a child’s uniqueness with family members, siblings, or even to curious strangers. Finding the right words can be even harder if your child is newly diagnosed, or if very little is known about what to expect in the future.

 The books summarized below address uniqueness, inclusion, even genetic/chromosomal differences. These frank, but endearing stories can better arm parents and caregivers with the language to talk about their child’s differences.

Read More

Rare Genomics Institute Demonstrates the Power of Genomenon's AI-Based Technology in Diagnosis

/
Rare Genomics Institute Demonstrates the Power of Genomenon's AI-Based Technology in Diagnosis

LOS ANGELES, CA; February 28, 2019 -- Rare Genomics Institute, a nonprofit providing direct support to undiagnosed rare disease patients, announced on Rare Disease Day that they were able to diagnose a previously undiagnosed patient with the use of the Mastermind® Genomic Search Engine, a clinical decision support tool by Genomenon®.

The Patient Research Services of the Rare Genomics Institute has created an ecosystem of leading technology partners and genetic experts from top research institutions around the world to give patients pro-bono access to world-class genomic sequencing, data analysis and interpretation services. Often, Rare Genomics works with their partners and volunteer experts to re-analyze cases that have hit a dead end.

Read More

A Rare Genomics patient is diagnosed using Genomenon’s Mastermind Search Engine

/
A Rare Genomics patient is diagnosed using Genomenon’s Mastermind Search Engine

Los Angeles, CA; February 27, 2019: Getting a diagnosis for a rare disease is a long and often painful journey that can take an average of five years and hundreds of doctor visits. Sometimes, the answer never comes; conventional diagnostics does not always provide a diagnosis for diseases that are only found in one in a million or one in 10 million people. Because most rare diseases are genetic in nature, genomic DNA sequencing can be used to provide answers that conventional approaches cannot.

Most families affected with rare diseases are under financial strain, making access to genetic sequencing technologies difficult. Rare Genomics Institute, a non-profit patient advocacy group, meets these patients at the end of their diagnostic odyssey – when all other means of diagnosis have failed and when financial resources are no longer available to continue the diagnostic process. Rare Genomics has created an ecosystem of leading technology partners and genetic experts from top research institutions around the world to give patients access to world-class genomic sequencing, data analysis and interpretation services. Often, Rare Genomics works with their partners and volunteer experts to re-analyze cases that have hit a dead end. 

Read More

Bridging Health and Social Care for Rare Disease Day 2019

/
Bridging Health and Social Care for Rare Disease Day 2019

Rare Disease Day is held annually on the last day of February to raise awareness about rare diseases. This effort is targeted at the general public as well as those who influence legislation, research, and healthcare decisions that affect rare disease patients. The first Rare Disease Day took place on February 29, 2008. Since this day only occurs every four years on a leap year, it signifies the rarity of rare disease.

The theme of this year’s Rare Disease Day is “bridging health and social care”. This addresses the need for better coordination of all aspects of rare disease care including medical, social, and support services. The theme sheds light on how performing daily tasks can be difficult for rare disease patients and their caretakers. Activities such as cooking a meal, shopping, and cleaning the house can be difficult or impossible for someone with a disability.

Read More